SCHEMBL29908014

SCHEMBL29908014

O=C(N[C@H](Cc1ccccc1F)C(=O)O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MDM4 O15151 3/20 0.54
TP53 P04637 3/20 0.54
MDM2 Q00987 6/20 0.54
CASP3 P42574 2/20 0.49
SLC17A5 Q9NRA2 1/20 0.48
KMT2A Q03164 2/20 0.46
TLR2 O60603 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30759437 1.00 MDM4 (0.54) MDM4TP53MDM2CASP3SLC17A5
SCHEMBL119553 1.00 MDM4 (0.54) MDM4TP53MDM2CASP3SLC17A5
SCHEMBL29928742 1.00 MDM4 (0.54) MDM4TP53MDM2CASP3SLC17A5
SCHEMBL119590 1.00 MDM4 (0.54) MDM4TP53MDM2CASP3SLC17A5
SCHEMBL3724545 1.00 MDM4 (0.54) MDM4TP53MDM2CASP3SLC17A5
SCHEMBL29401176 1.00 MDM4 (0.54) MDM4TP53MDM2CASP3SLC17A5
SCHEMBL25185746 0.92 MDM4 (0.52) MDM4TP53MDM2CASP3SLC17A5
SCHEMBL25657518 0.92 MDM4 (0.52) MDM4TP53MDM2CASP3SLC17A5
SCHEMBL30422430 0.92 MDM4 (0.52) MDM4TP53MDM2CASP3SLC17A5
SCHEMBL22636173 0.89 MDM2 (0.60) MDM4TP53MDM2CASP3SLC17A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001924-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME NEW YORK UNIVERSITY (US) 2026-01-01 US disclosed
US-12371461-B2 Nemo coiled coil mimics and methods of using same NEW YORK UNIVERSITY (US) 2025-07-29 US disclosed
EP-3303367-B1 STABILIZED MINIMAL COILED-COIL MIMETICS UNIV NEW YORK (US) 2025-06-18 EP disclosed
US-20240190930-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME UNIV NEW YORK (US) 2024-06-13 US disclosed
US-20240124539-A1 CROSSLINKED HELIX DIMER MIMICS OF SOS AND METHODS OF USING SAME NEW YORK UNIVERSITY 2024-04-18 US disclosed
US-11891422-B2 NEMO coiled coil mimics and methods of using same NEW YORK UNIVERSITY (US) 2024-02-06 US disclosed
US-20220289802-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME CORNELL UNIVERSITY 2022-09-15 US disclosed
US-11440938-B2 Stabilized minimal coiled-coil mimetics NEW YORK UNIVERSITY (US) 2022-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12371461-B2 Nemo coiled coil mimics and methods of using same COIL, CALCOCO2, NCAPH MDM4 2743/4885TP53 3446/4885MDM2 777/4885
US-11440938-B2 Stabilized minimal coiled-coil mimetics COIL, CALCOCO2, SMC2 MDM4 256/4885TP53 657/4885MDM2 420/4885
US-20240124539-A1 CROSSLINKED HELIX DIMER MIMICS OF SOS AND METHODS OF USING SAME SOS2, SOS1, F2 MDM4 2834/4885TP53 2795/4885MDM2 405/4885
US-20260001924-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME DDX21, PHAX, RBX1 MDM4 2407/4885TP53 2772/4885MDM2 908/4885
US-11891422-B2 NEMO coiled coil mimics and methods of using same COIL, CALCOCO2, NCAPH MDM4 2743/4885TP53 3446/4885MDM2 777/4885
US-20220289802-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME COIL, CALCOCO2, NCAPH MDM4 2743/4885TP53 3446/4885MDM2 777/4885
US-20240190930-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME COIL, CALCOCO2, NCAPH MDM4 2503/4885TP53 3371/4885MDM2 678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.